Skip to main content

Table 3 Prediction accuracy of the trans-ancestry T2D PRS in four Black cohorts

From: Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations

Cohort

Liability

R2

Covariates-adjusted AUC

OR per SD

(95% CI)

Top 2% PRS

OR

(95% CI)

P value

Sensitivity

Specificity

Adjusted PPV*

Adjusted NPV*

REGARDS

4.6%

0.61

1.70

(1.58, 1.84)

3.04

(2.15, 4.31)

3.87E−10

0.04

0.99

0.30

0.88

GenHAT

3.6%

0.61

1.85

(1.70, 2.01)

2.70

(1.74, 4.18)

8.44E−06

0.03

0.99

0.26

0.88

HyperGen

6.2%

0.62

1.75

(1.52, 2.02)

3.37

(1.69, 6.69)

5.37E−04

0.05

0.99

0.34

0.88

Warfarin

1.5%

0.57

1.37

(1.13, 1.65)

2.70

(0.80, 9.09)

1.09E−01

0.01

0.98

0.07

0.87

  1. *Adjusted PPV and NPV are calculated using 12.5% for the African population